Patient recorded integrated measurements
Recruiting
- Conditions
- cancer cachexia - emaciation in cancer10027656
- Registration Number
- NL-OMON54788
- Lead Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 322
Inclusion Criteria
• Age >= 18
• Diagnosed with gastric-, oesophageal-, colorectal, hepatobiliary-,
pancreatic- or ovarian cancer
• Planned for primary surgery neo-adjuvant chemotherapy
Exclusion Criteria
• ASA-classification V,
• severe liver cirrhosis Child grade C,
• end stage renal disease requiring dialysis,
• severe heart disease New York Heart Association class IV,
• chronic obstructive pulmonary disease (COPD) requiring (home)oxygen therapy,
• Patients must be *mobile*. They may not be bedridden or in a wheelchair.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary objective of this study is to obtain accurate data regarding<br /><br>physical activity and body weight loss over time in patients with gastric-,<br /><br>oesophageal-, colorectal-, hepatobiliary-, pancreatic-, and ovarian cancer, and<br /><br>relate this to adverse events of their treatment (postoperative complications<br /><br>and/or chemotoxicity).</p><br>
- Secondary Outcome Measures
Name Time Method <p>1. To evaluate the association between adverse events (postoperative<br /><br>complications and/or chemotoxicity) and change in body weight and physical<br /><br>activity in patients with gastric-, oesophageal-, colorectal-, hepatobiliary-,<br /><br>pancreatic-, and ovarian cancer.<br /><br>2. To assess the relationship between body weight loss/physical activity and<br /><br>treatment outcome/survival.<br /><br>3. To assess the validity of di-electric probe measurements for assessing<br /><br>muscle mass.</p><br>